Professor Steven Bova, based at the University of Tampere, Finland, and head of ICGC prostate cancer UK metastatic studies, said: «The diversity we've found
suggests multiple biopsies might be needed to identify the «trunk» of the cancer's tree of mutations — we need treatments that target these core weaknesses to destroy all cancer cells in a clean sweep, rather than trimming the branches.
In a recent study histopathological findings in dogs with pancreatitis were highly localized,
suggesting that even if
multiple biopsies are being collected, pancreatic inflammation, especially in cases of chronic pancreatitis, may be easily missed.